The [4] . Clinically important characteristics of tracheal function are more dependent on tracheal collapsibility and studies should probably focus on measuring tracheal compliance instead. [5] . The authors also do not comment on immune response directed to recellularized tracheal allografts despite the growing evidence of the immunomodulatory role of mesenchymal stem cells [6] . Theoretically, ECM components are considered to be conserved between species and individuals; however, inflammatory reactions and hyperacute rejection to these natural scaffolds have been reported [7] and traditional histological methods are far too simplistic to predict long term remodelling outcome. 
preservation of function of decellularized organs is a key concept in this area of research. Repetitive cycles of their detergent-enzymatic method, ranging from 17 cycles for porcine tracheas to 25 cycles for human tracheas, allowed for preservation of biomechanical strength and induced loss of antigenicity. Structural integrity of these tracheal grafts was measured only by using a tensile-test device and exposing tracheas to increasing uniaxial force where, the tracheal rupture point was measured

In addition, immunogenicity of tracheal grafts in this porcine model was assessed by using immunohistochemical methods to determine the number of cycles required, in combination with the expression of an inflammatory marker and the development of anti-pig leucocyte antigen antibodies in mice implanted with porcine bioengineered tracheas [4]. Immunogenicity in their clinical transplantation was assessed by immunostaining for Major Histocompatibility Complex Class I (MHCI) and Major Histocompatibility Complex Class II (MHCII) markers on tracheal sections following decellularization
